Finding novel prognostic factors in metastatic renal cell carcinoma: what does peripheral blood tell us?-Reference-Cited by-同舟云学术

Finding novel prognostic factors in metastatic renal cell carcinoma: what does peripheral blood tell us?

Published:2022-05 Issue:3 Volume:74 Page:
ISSN:2724-6051
Container-title:Minerva Urology and Nephrology
language:
Short-container-title:Minerva Urol Nephrol

Author:

MARANDINO Laura,CAMPI Riccardo,ERDEM Selçuk,BERTOLO Riccardo,MARCHIONI Michele,INGELS Alexandre,KARA Önder,CARBONARA Umberto,PECORARO Angela,PAVAN Nicola,MUSELAERS Stijn,ROUSSEL Eduard,AMPARORE Daniele,

Publisher

Edizioni Minerva Medica

Subject

Urology,Nephrology

Link

https://www.minervamedica.it/pdf.php?cod=R19Y2022N03A0372

Reference21 articles.

1. Cytoreductive Nephrectomy in 2021: Obsolete but Necessary

2. Impact of frailty on perioperative and oncologic outcomes in patients undergoing surgery or ablation for renal cancer: a systematic review

3. Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide;Pisano C;Minerva Urol Nephrol,2021

4. Systematic review of neoadjuvant therapy by immune checkpoint inhibitors before radical cystectomy: where do we stand?

5. A New Therapeutic Era for Metastatic Renal Cell Carcinoma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thermal ablation for T1b renal cancer: an "I wish I could, but I cannot?";Minerva Urology and Nephrology;2024-05

2. Metastatic de-novo renal cell carcinoma in the era of immune combinations: what can we learn from real-world data?;Minerva Urology and Nephrology;2024-03

3. Renal cell carcinoma with non-clear cell histologies: all the same peas in one pod?;Minerva Urology and Nephrology;2023-08

4. Morbidity and mortality of metastasectomy for renal cell carcinoma: is centralization of care the way forward?;Minerva Urology and Nephrology;2023-05

5. The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease;Minerva Urology and Nephrology;2023-03